Introduction
Epilepsy is among the most burdensome neurological conditions worldwide [
1]. Prognosis is heterogeneous and depends on the underlying etiology, epilepsy syndrome, and treatment response. Although many patients achieve adequate seizure control, a substantial proportion develop drug-resistant epilepsy, which is associated with cognitive and neuropsychiatric comorbidities [
1]. Among epilepsy syndromes presenting in young infants, infantile epileptic spasms syndrome (IESS), formerly known as infantile spasms or West syndrome, is one of the most severe forms of developmental and epileptic encephalopathy [
2]. The overall prognosis of IESS is poor. Long-term follow-up studies have documented cognitive impairment in up to 86% of affected children and physical disability in approximately 70% of them [
3]. Although catastrophic epilepsy was first identified more than 160 years ago, its causes and mechanisms remain poorly understood [
1,
4].
Stress is a constant part of life. Thus, harm to the fetus may be substantial if stress persists throughout pregnancy. In particular, prenatal stress has been demonstrated to cause central nervous system disorders in infants, such as alterations in the hypothalamic-pituitary-adrenal axis [
5] and epilepsy [
6]. Dysfunction of the gamma-aminobutyric acid (GABA)ergic signaling system causes numerous neuropsychiatric disorders, including autism spectrum disorder [
7], schizophrenia [
8], and epilepsy [
9,
10]. Prenatal stress disrupts the excitatory/inhibitory shift during cerebral development, which may result in increased susceptibility to spasms. Baek et al. [
10] demonstrated that prenatal exposure to acute immobilization stress (AIS) leads to increased susceptibility to infantile spasms [
10]. Nevertheless, given the diversity of stressors, different responses may be expected depending on stress severity.
Psychological stress is the most frequent self-reported seizure precipitant among patients with epilepsy. However, clinical evidence consistently demonstrates that chronic, sustained stress has a greater adverse effect on seizure frequency than isolated acute stressors [
11]. In a controlled prospective study of 64 children with epilepsy, a structured 6-week seizure-stress diary indicated that 62% of those who experienced at least one seizure during the diary period showed a positive association between daily stress levels and seizure occurrence. Paradoxically, stress-sensitive patients also exhibited a blunted response to a discrete acute psychosocial stressor, suggesting that seizure-promoting effects operate through chronic stress exposure rather than acute reactivity alone [
12].
Maternal stress during pregnancy activates systemic immune responses and increases proinflammatory cytokines, including interleukin (IL)-6 [
13], IL-1β, and tumor necrosis factor-α (TNF-α). These cytokines can reach the fetal compartment by crossing the placenta [
14]. These inflammatory mediators have been shown to disrupt normal neurodevelopment and to modulate the excitatory–inhibitory balance, a critical determinant of seizure susceptibility [
15].
Thus, we investigated the effects of prenatal stress on GABAergic signaling using AIS and chronic immobilization stress (CIS) models and evaluated seizure susceptibility using an N-methyl-D-aspartate (NMDA)-induced spasm-like seizure model.
Discussion
In this study, we investigated whether prenatal immobilization stress, particularly CIS, increases susceptibility to NMDA-induced spasm-like seizures in infant rats and examined associated changes in GABAergic signaling and glial activation. Our main findings can be summarized as follows: (1) chronic prenatal stress lowered the threshold for NMDA-induced spasm-like seizures, producing a greater increase in spasm frequency than acute prenatal stress (AIS); (2) prenatal stress, whether acute or chronic, was associated with reduced cortical GAD67 immunoreactivity; (3) prenatal stress was associated with astrocyte and microglial activation and upregulation of proinflammatory mediators after NMDA challenge; (4) acute and chronic prenatal stress appeared to have distinct, rather than simply graded, biological consequences, as reflected by differing microglial morphological responses between the AIS and CIS groups; and (5) several methodological limitations, discussed below, temper the interpretation of these findings. It should be noted that although the CIS group showed the greatest increase in spasm frequency, the AIS and CIS groups did not differ consistently across all outcome measures, suggesting that acute and chronic prenatal stress may engage both overlapping and distinct mechanisms rather than a simple linear dose-response relationship.
IESS are a form of developmental and epileptic encephalopathy that occurs in early childhood. In many cases, patients do not receive adequate medical therapy, which is usually responsible for the observed developmental delay. Understanding the cryptogenic etiology of this condition remains challenging [
2-
4]. However, various hypotheses are currently being explored. Determining the cause of a seizure is important for defining the treatment target. Thus, studies examining the mechanisms underlying IESS also contribute to research aimed at understanding developmental delays.
In our study, prenatal exposure to CIS, coupled with postnatal NMDA-triggered spasm-like seizure induction, increased spasm frequency and decreased spasm latency compared with control conditions, with a greater increase observed in the CIS group than in the AIS group for spasm frequency. Prior work using the AIS model reported decreased KCC2 expression and increased intracellular Cl− concentration in GABAergic neurons, together with a depolarized resting membrane potential, and proposed that these changes could lower the threshold for spasm-like seizures [
10]. KCC2 expression and membrane potential were not directly assessed in the present study; therefore, the reduced cortical GAD67 immunoreactivity we observed in the CIS group should be regarded as indirect, associative support for—rather than direct confirmation of—the hypothesis that disrupted chloride homeostasis and impaired GABAergic inhibition contribute to prenatal stress-related spasm susceptibility. Direct assessment of KCC2 expression and chloride handling in the CIS model, together with dose-response characterization of the stress exposure required to alter this pathway, will be necessary in future studies to test this hypothesis.
Consistent with the greater spasm frequency observed in the CIS group, several clinical studies similarly report that chronic stress has a more pronounced adverse effect on seizures than acute stress. Psychological stress is consistently identified as the most frequently self-reported seizure precipitant among patients with epilepsy. However, clinical evidence demonstrates that its effects on seizure severity and frequency are not uniform and that chronic stress exerts more pronounced and sustained adverse effects than acute stress [
11]. A prospective diary study in patients with localization-related epilepsy demonstrated that incrementally higher levels of sustained self-reported stress and anxiety were significantly associated with an increased probability of seizure occurrence on the following day (odds ratios: 1.06 and 1.07 per unit increase), supporting the dose-dependent, cumulative nature of chronic stress on seizure susceptibility [
22]. In a controlled clinical study of 64 children with epilepsy using the Trier Social Stress Test and a 6-week seizure-stress diary, children whose seizures were triggered by acute stress showed a paradoxically blunted cortisol response to acute psychosocial stimuli compared to the control group [
12]. Direct human tissue evidence from surgical specimens of patients with temporal lobe epilepsy has demonstrated that chronic glucocorticoid receptor activation, consistent with chronic stress, impairs long-term potentiation in the human temporal cortex. This mechanism is distinct from the transient modulatory effects of acute glucocorticoid exposure, suggesting that chronic stress independently undermines synaptic homeostasis, thereby exacerbating epilepsy [
23].
A key limitation of this study is that spasm-like events were identified based on behavioral observation alone, without electroencephalographic (EEG) confirmation, and the animals did not exhibit spontaneous seizures; the NMDA-induced events described here should therefore be regarded as a pharmacologically provoked spasmlike model rather than a full electroclinical correlate of IESS. Other studies using similar models have reported EEG findings and drug-response profiles consistent with IESS [
10,
24].
This study has several limitations that should be acknowledged. First, each group (CTL, AIS, and CIS) consisted of only 5 animals, and sample size was not derived from a formal a priori power calculation; the present findings should therefore be regarded as preliminary, and adequately powered replication studies with larger cohorts are warranted. Second, although we report the number of offspring analyzed per group, we did not clearly report the number of dams per group or explicitly model litter as a random effect; because pups from the same litter are not statistically independent, this raises the possibility of pseudoreplication, and future studies should report dam and litter numbers and consider litter-based statistical models. Third, this study did not include no- NMDA control groups—that is, CTL, AIS, and CIS animals that were not challenged with NMDA and were not monitored over an extended baseline period. As a result, we cannot fully exclude the possibility that spontaneous epileptiform activity could occur independently of NMDA, nor can we fully distinguish the direct, baseline effects of prenatal stress from NMDA-induced excitotoxic or postictal changes in GAD67 immunoreactivity and glial activation; consequently, our mechanistic interpretations should be tempered accordingly, and future studies incorporating nonchallenged, stress-only cohorts with continuous long-term monitoring would help clarify the independent contribution of prenatal stress alone. Fourth, qRT-PCR analysis of proinflammatory mediators (
Fig. 4H) was performed only in CTL and CIS animals; the AIS group was not included, so it remains unknown whether AIS produces similar transcriptional changes. Fifth, although the CIS group showed the greatest increase in spasm frequency, the AIS and CIS groups did not differ consistently across all outcome measures—for example, in microglial morphological complexity after NMDA challenge, AIS microglia retained a more ramified, surveillance-like morphology, whereas CIS microglia showed a more deramified, activated profile similar to that seen after NMDA challenge alone. This distinction may reflect different microglial priming states following acute versus chronic prenatal stress (a more transient, adaptive response after a single stressor versus a more persistently reactive phenotype after repeated stress), but given the limitations noted above, this interpretation remains speculative and suggests that acute and chronic prenatal stress may not simply produce graded effects of differing magnitude. Sixth, neuroinflammatory changes were examined only at P15, the developmentally validated age for this NMDA-induced infantile spasms model; we therefore cannot determine whether these effects are transient or persist beyond this age-specific window, and future studies comparing multiple postnatal ages would help clarify their developmental specificity. Finally, the associations observed among neuroinflammation, reduced GAD67 immunoreactivity, and increased spasm susceptibility do not establish causality; interventional studies using anti-inflammatory treatments or GABAergic rescue approaches, together with no-NMDA controls, will be required to test whether these changes causally contribute to the phenotype.
Although sex differences in seizure susceptibility are well established in adult rodents, this dimorphism is largely absent at P15. Immature rats show no sex-specific differences in acute seizure susceptibility, unlike adults [
22], consistent with estradiol manipulation having no effect on spasms in this model around the same age [
23]. This likely reflects the fact that sex differences in seizure susceptibility depend on gonadal hormones that intensify only after puberty [
24], a window P15 precedes. We note that regional KCC2 dimorphism has been reported at P15 [
25], but this does not appear to produce a measurable wholeanimal difference in spasm susceptibility, so we did not stratify our analyses by sex.
Although AIS has previously been associated with seizures, the relevance of CIS to seizures remains uncertain. Ahmadzadeh et al. [
26] reported that short-term prenatal stress increased susceptibility to pilocarpine-induced seizures. Many studies have reported that chronic prenatal stress is associated with depression [
27], memory impairment [
28], and even schizophrenia [
8]. However, the relationship between CIS and seizures remains unclear. Here, we found that chronic prenatal stress increased seizure susceptibility in the offspring.
In conclusion, our findings indicate that prenatal stress, particularly CIS, increases susceptibility to NMDA-induced spasm-like seizures in infant rats and is associated with reduced GAD67 immunoreactivity and enhanced glial activation. Because the present data demonstrate associations rather than causal relationships, future studies incorporating no-NMDA tissue controls, adequately powered litter-based designs, EEG confirmation, and interventional approaches such as anti-inflammatory or GABAergic rescue strategies will be needed to determine whether neuroinflammation and GABAergic dysfunction causally contribute to this phenotype.